Paroxysmal hypertension
{{Short description|Episodic high blood pressure}}
{{Infobox medical condition (new)
| name =
| synonym =
| image =
| image_size =
| alt =
| caption =
| pronounce =
| specialty = cardiology/psychiatry
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}
Paroxysmal hypertension is episodic and volatile high blood pressure, which may be due to stress of any sort, or from a pheochromocytoma, a type of tumor involving the adrenal medulla. {{citation needed|date=March 2021}}
Patients with paroxysmal hypertension who test negative for pheochromocytoma are said to be suffering from a clinical entity called "pseudopheochromocytoma." This disorder is due to episodic dopamine discharge and has been observed predominantly in hypertensive women whose presentation mimicked pheochromocytoma, but with subsequent testing being negative for malignancy. In patients with pseudopheochromocytoma, dopamine was found to be significantly increased post-paroxysm. The paroxysm is said to be similar to the hypertensive episodes described by Page in 1935, and has been colloquially referred to as "Page's Syndrome". These episodes can occur after diencephalic stimulation.{{cite journal |vauthors=Kuchel O |title=Pseudopheochromocytoma |journal=Hypertension |volume=7 |issue=1 |pages=151–8 |year=1985 |pmid=3980057 |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=3980057 |doi=10.1161/01.hyp.7.1.151|doi-access=free }}
The exact cause of pseudopheochromocytoma is unknown, though it is thought to be related to episodic dopamine discharge. External stressors that may contribute include pain, anxiety, or emotional trauma.*{{cite journal |vauthors=Kuchel O, Buu NT, Larochelle P, Hamet P, Genest J |title=Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited |journal=Archives of Internal Medicine |volume=146 |issue=7 |pages=1315–20 |year=1986 |pmid=3718127 |doi=10.1001/archinte.1986.00360190079011 }} Therefore, treatment of pseudopheochromocytoma is aimed at psychological support and intervention with antidepressants, but also treatment with alpha and then beta blockers in resistant cases.*{{cite journal |vauthors=Seck SM, Ka EF, Niang A, Diouf B |title=Pseudopheochromocytoma: An uncommon cause of malignant hypertension |journal=Indian Journal of Nephrology |volume=19 |issue=3 |pages=122–4 |year=2009 |pmid=20436734 |pmc=2859479 |doi=10.4103/0971-4065.57111 |doi-access=free }}
References
{{reflist}}
Further reading
- {{cite journal |vauthors=Kuchel O, Buu NT, Larochelle P, Hamet P, Genest J |title=Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited |journal=Archives of Internal Medicine |volume=146 |issue=7 |pages=1315–20 |year=1986 |pmid=3718127 |doi=10.1001/archinte.1986.00360190079011 }}
- {{cite journal |vauthors=Seck SM, Ka EF, Niang A, Diouf B |title=Pseudopheochromocytoma: An uncommon cause of malignant hypertension |journal=Indian Journal of Nephrology |volume=19 |issue=3 |pages=122–4 |year=2009 |pmid=20436734 |pmc=2859479 |doi=10.4103/0971-4065.57111 |doi-access=free }}
- {{cite journal |vauthors=Mann SJ |title=Severe paroxysmal hypertension (pseudopheochromocytoma) |journal=Current Hypertension Reports |volume=10 |issue=1 |pages=12–8 |year=2008 |pmid=18367021 |doi=10.1007/s11906-008-0005-2|s2cid=36584198 }}
- {{cite journal |vauthors=Páll A, Becs G, Erdei A, Sira L, Czifra A, Barna S, Kovács P, Páll D, Pfliegler G, Paragh G, Szabó Z |title=Pseudopheochromocytoma induced by anxiolytic withdrawal |journal=European Journal of Medical Research |volume=19 |pages=53 |year=2014 |issue=1 |pmid=25288254 |pmc=4196012 |doi=10.1186/s40001-014-0053-9 |doi-access=free }}
External links
- [http://www.gpnotebook.co.uk/simplepage.cfm?ID=-1174011864 GPnotebook entry]
{{med-sign-stub}}